Neogen Price Target Cut to $13.00/Share From $16.50 by Piper Sandler
Piper Sandler Reiterates Neutral on Neogen, Lowers Price Target to $13
Neogen Analyst Ratings
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $13
Piper Sandler Keeps Their Hold Rating on Neogen (NEOG)
Guggenheim Initiates Neogen(NEOG.US) With Buy Rating, Announces Target Price $15
Neogen Analyst Ratings
Guggenheim Initiates Coverage on Neogen With Buy Rating, $15 Price Target
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $16.5
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $16.5
Neogen Analyst Ratings
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $17.5
Neogen (NEOG) Gets a Hold From Piper Sandler
Neogen Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)
Neogen Analyst Ratings
Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $17.5
Neogen Analyst Ratings
Wells Fargo Maintains Overweight on Neogen, Raises Price Target to $28
Neogen Analyst Ratings